Latest Manufacturing News

Tivan Limited has received $150,000 in exploration grants from the Northern Territory Government to advance its promising Sandover Fluorite Project, supporting maiden drilling and metallurgical testwork.

BluGlass Limited has become an approved supplier to the Indian Ministry of Defence, landing its first $230,000 order for gallium nitride laser development from a leading Indian research lab.

Cardiex Limited has announced a fully underwritten 1-for-4 entitlement offer at $0.04 per share, aiming to raise approximately $4.1 million to advance manufacturing and scale its supply chain. The offer closes on 20 June 2025, following a recent $2.4 million placement.

Clarity Pharmaceuticals reports that its Cu-SARTATE diagnostic agent significantly outperforms the current standard in detecting neuroendocrine tumours, paving the way for a pivotal Phase III study.

Maggie Beer Holdings has agreed to sell its subsidiary Paris Creek Farms for $500,000, aiming to sharpen focus on its core premium brands and achieve significant cashflow savings.

IperionX has secured a significant U.S. Department of Defense contract worth up to US$99 million to supply low-cost, high-performance titanium components, marking a major step in reshoring critical materials manufacturing.

Wide Open Agriculture Ltd has announced a Share Purchase Plan aiming to raise up to $500,000 through the issue of new shares and free-attaching options, pending shareholder approval. This capital raise complements a recent $2.6 million placement to support the company’s growth and production ramp-up.

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

Elsight has landed a significant US$5.08 million contract with a European defence OEM, pushing its total 2025 orders from this customer to nearly US$14.7 million and signaling strong growth in unmanned systems connectivity.

Cann Group Limited has resolved its legal dispute with Rua Biosciences, paving the way for new commercial agreements to supply medicinal cannabis products across Australia and New Zealand.

InhaleRx has secured swift Human Research Ethics Committee approval for its redesigned IRX-211 Phase 2 trial, expanding participant numbers and potentially bypassing Phase 3 to speed market entry.